A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
about
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsCirculating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filtersCurrent Status of CTCs as Liquid Biopsy in Lung Cancer and Future DirectionsImproving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersDetection of circulating tumor cellsCirculating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer researchIsolation of rare tumor cells from blood cells with buoyant immuno-microbubblesPancreatic cancer: Are "liquid biopsies" ready for prime-time?Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic CancerAcquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.The Potential for Circulating Tumor Cells in Pancreatic Cancer Management.Pancreatic biomarkers: could they be the answer?Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells.Circulating tumor cells in pancreatic cancer patients: enrichment and cultivationDo circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology"Tissue is the issue": circulating tumor cells in pancreatic cancer.A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.A meta-analysis of extended versus standard lymphadenectomy in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinomaCirculating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancerThe detection of EpCAM(+) and EpCAM(-) circulating tumor cells.Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic FindingsDetection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent ApproachesCediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells.Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.Cytokeratin-based CTC counting unrelated to clinical follow upOptical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell.Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
P2860
Q26739062-F68DE485-4F20-45C3-B453-5E418DCF0863Q26778909-09695D71-CB83-48AE-9912-FA1E4A0CBF9FQ26781333-23DA42DB-77BD-4972-827A-48D548D96962Q26782719-78D754AE-73BD-496C-847C-46C1401E0143Q26822406-B25AD59F-33A4-4B3E-9610-ECA0B57C474AQ26859334-A330ABED-CCA7-49A1-89CF-923A79BBD52BQ27024191-6D22CBA6-9E44-4BC8-AE23-576DBBCDFBEAQ27335994-4E49D81D-41BC-485F-A028-1E41425AF589Q28068665-1C7931A6-E284-408F-8F39-E3AC096FEE73Q28073765-33586690-EE06-49D3-874A-F50CB17ABFAFQ30376511-757FCF5F-B2FB-434A-B7CE-B9B1F483D366Q30558415-9B15B4E4-9153-40E0-95AD-28A374DE72DAQ33579810-A90DF071-1255-4319-8CFA-80092FB57262Q33624194-80AE677F-D838-4217-A032-DAF7E4840A1FQ33753267-9D5F45DF-15A1-4A19-BC4B-6AD7296C2AB2Q33801371-DBADA493-7013-4B73-BC3B-59A23CBCCB5AQ33803923-DBB47B9E-E310-45CA-87E0-4FBA6D6534ADQ35039154-76ED7C2A-9189-46BE-866E-B609FD9EA7F8Q35133088-F3854C24-426C-4FB8-86CD-2AC6966438ABQ35506933-4014BAF6-00FE-4915-9376-81804D2FDAE9Q35543094-7E4EAA35-FF14-4F58-896D-10CF3A0A0D08Q35634662-B5015152-C803-4B61-9E22-BC3939D405BDQ35681674-C65D818A-2501-4A80-8C1A-722A12C95770Q35761088-237BF2BD-CB8F-4B52-8287-3B560748C3A7Q35820329-FA9988C5-1D9E-445F-ABC8-DA2A067D5328Q35860287-36B11C66-C793-4422-9B8B-791D0ACBB533Q35988678-9C21B6EB-A4DC-4CD6-9F57-0005F7CE16CBQ36213034-F772198F-0C71-445E-B678-42618A4858E0Q36242936-0BCB7CDB-16F3-4CF3-A8EE-47762E0E1627Q36255936-C495F627-9A26-4338-BDA0-7463F8D50EE7Q36287599-A2758897-24A9-4235-8B57-86062950D3C7Q36388852-4DE14D44-9648-4E69-A74F-C4EC4FDDFDC6Q36790514-C736CB8B-3692-4172-9591-C690838C5C29Q36935205-2D8E761D-0D47-47CD-86DC-0779B55B8576Q37075334-E489E722-92BE-45E3-B916-17411C08486DQ37174021-864A16CF-4785-4C43-B398-CEA61D50A22FQ37274573-FB88A11D-69F7-47D4-B3F5-94A751CCFE19Q37467334-CE155FEB-6211-4E25-88A6-31EB7769F24AQ37569045-3AA708EC-EE23-4711-94AB-D2BEC43D14B9Q37662347-15BFCBA4-B97D-4CF2-B8EA-E829D14BDB56
P2860
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A pilot study to explore circu ...... c cancer as a novel biomarker.
@ast
A pilot study to explore circu ...... c cancer as a novel biomarker.
@en
A pilot study to explore circu ...... c cancer as a novel biomarker.
@nl
type
label
A pilot study to explore circu ...... c cancer as a novel biomarker.
@ast
A pilot study to explore circu ...... c cancer as a novel biomarker.
@en
A pilot study to explore circu ...... c cancer as a novel biomarker.
@nl
prefLabel
A pilot study to explore circu ...... c cancer as a novel biomarker.
@ast
A pilot study to explore circu ...... c cancer as a novel biomarker.
@en
A pilot study to explore circu ...... c cancer as a novel biomarker.
@nl
P2093
P2860
P50
P356
P1476
A pilot study to explore circu ...... ic cancer as a novel biomarker
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2011.545
P407
P577
2011-12-20T00:00:00Z
P5875
P6179
1018844773